Insolation Energy Limited (BOM:543620)

Market Cap	49.39B
Revenue (ttm)	13.34B
Net Income (ttm)	1.26B
Shares Out	220.34M
EPS (ttm)	5.95
PE Ratio	37.67
Forward PE	n/a
Dividend	0.10 (0.04%)
Ex-Dividend Date	n/a

Volume	319,500
Average Volume	321,950
Open	224.55
Previous Close	220.00
Day's Range	221.50 - 229.80
52-Week Range	205.50 - 475.00
Beta	-0.56
RSI	40.36
Earnings Date	Aug 7, 2025

About Ligand Pharmaceuticals

Insolation Energy Limited engages in the manufacture and sale of solar panels and modules under INA brand name in India. The company provides monocrystalline passive emitter and rear cell and polycrystalline solar photovoltaic (PV) modules for use in various applications, such as on-grid large scale utility system, on-grid rooftop residential and commercial system, net metering solution, off-grid residential system, solar pumping applications, rural electrification, green telecom tower, solar street light, solar home lighting system, solar lant...

• Industry: Semiconductors and Related Devices
• Founded: 2015
• Employees: 241
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543620

Financial Performance

In 2024, Insolation Energy's revenue was 13.34 billion, an increase of 80.93% compared to the previous year's 7.37 billion. Earnings were 1.26 billion, an increase of 127.50%.